Skip to content

Evaluation of Indicators of Anxiety, Depression, Stress, Quality of Life and Frequency Severity, and Duration of Migraine Attacks under the Influence of Psymentology Consciousness Fields

Soraya Behboodi, M. Taheri

The Scientific Journal of Cosmointel April 17, 2022 DOI: 10.61450/joci.v1i5.42 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 30
Population Patients with chronic migraine referred to the Migraine Clinic in Tehran, Iran, aged 18-60 (22 females, 8 males)
Intervention routine migraine treatment
Duration 12 weekly sessions of 90 minutes; 3-month follow-up
Measures MSQ v2.1 (Migraine-specific Quality of Life Questionnaire), DASS42 (Depression, Anxiety, and Stress Scale), IHS-standard migraine form
Topics Anxiety Depression
Key findings Psymentology sessions with Taheri Consciousness Fields significantly reduced depression, anxiety, and stress by 23%, 20%, and 13% respectively compared with routine treatment alone, and had a significant effect on migraine attack severity and duration. Quality of life showed no significant improvement over the three-month study period.

Abstract

Psymentology is one of the fields in Complementary and Alternative Medicine in Iran, and concerning Mind-Psychology, founded and introduced by Mohammad Ali Taheri (having over 40 years of history). This complementary medicine has a supra-holistic view of human beings. It aims at the cognition of humans and their existential software as well as diagnosis and treatment of human psychological problems through establishing the connection between the components and constituents that is the subject of the study, and it is the Cosmic Consciousness Network (CCN). The purpose of this study was to evaluate the effects [of exposure to] Taheri Consciousness Fields (TCFs) via Psymentology (as one of the many TCFs) on the indicators of headache and psychic disorders caused by chronic migraine (such as depression, anxiety and stress), and the quality of life in patients. The research was performed among the patients with chronic migraine referred to the Migraine Clinic in Tehran (the capital of Iran), which was approved by a neurologist, 30 patients (22 females and 8 males between 18 and 60 years old) were randomly selected. Patients were divided into two groups: control and experimental groups. Before starting the study, each patient completed the MSQ v2.1 (Migraine-specific Quality of Life Questionnaire), and DASS42 (Depression, Anxiety, and Stress Scale) questionnaires under expert supervision. In addition, they received a migraine form in accordance with IHS (International Headache Association) standards designed to take notes during treatment. Two groups in the present study began their routine migraine treatment under the supervision of physicians. Moreover, the experimental group was justified by the researchers of the present study to use Psymentology sessions to complete the treatment process. The Psymentology approach consisted of 12 sessions, once a week, for 90 minutes of attending sessions. After presenting the theory required for the study method, the experimental group of patients was affected by TCFs for 20 minutes. After completing the number of Psymentology sessions and completing three months of conventional migraine treatment by the two groups of patients, the questionnaires were completed again, and the experts analyzed the completed forms during this period. Depression, anxiety, and stress were significantly reduced in the experimental group compared to the control group by 23, 20 and 13%, respectively (p value<0.05). On the other hand, considering the short-term quarterly study of chronic migraine headaches, its effect on the quality of life in this study was not significant. In headache indices, Psymentology Consciousness Fields had a meaningful effect on the severity and duration of migraine attacks. The frequency of seizures due to symptoms of discharge (as explained to patients before beginning the study) was 22% higher than the control group (p-value= 0.004). The duration of migraine attacks in patients undergoing the Psymentology Consciousness Fields effect showed a decrease of about 2% (p-value = 0.009).

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Explore topics